Study guide
12.4 Neonatal Hyperbilirubinemia & Phototherapy
AMCB Certified Nurse-Midwife CNM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care
1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral
2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts
2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy
3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy
3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy
4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss
4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care
5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance
5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation
6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy
7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair
7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture
8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation
8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications
9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation
10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health
10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination
11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes
12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days
12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days
13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization
13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening
14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation
14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral
15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders
15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome
16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis
17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions
17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking
18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity
18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care
12.4 Neonatal Hyperbilirubinemia & Phototherapy
Key Takeaways Explain This Topic AI
Jaundice appearing within the first 24 hours of life is always pathologic and requires immediate evaluation for hemolysis.
Breastfeeding jaundice appears in the first week from inadequate intake and is treated by increasing feeding frequency, while breast milk jaundice appears later and persists for weeks.
Visual estimation of jaundice is unreliable, so transcutaneous or serum bilirubin must be plotted on an hour-specific nomogram.
Phototherapy converts unconjugated bilirubin to water-soluble isomers by photoisomerization, allowing excretion without hepatic conjugation.
Acute bilirubin encephalopathy progressing to kernicterus is the outcome phototherapy and exchange transfusion exist to prevent.
Last updated: September 2026
Neonatal Hyperbilirubinemia: Metabolism, Diagnosis & Phototherapy
Jaundice affects approximately 60% of term and 80% of preterm infants. While predominantly benign, severe unconjugated hyperbilirubinemia can cross the blood-brain barrier, precipitating acute bilirubin encephalopathy and irreversible neurologic damage ( kernicterus ).
Bilirubin Metabolism Overview
Production: Senescent erythrocytes are degraded by reticuloendothelial macrophages, converting heme into unconjugated (indirect) bilirubin . Neonates produce two to three times more bilirubin than adults (8 to 10 mg/kg/day) due to higher hematocrit (50%–60%) and shorter erythrocyte lifespan ( 70 to 90 days in neonates vs. 120 days in adults).
Transport: Unconjugated bilirubin is lipophilic, water-insoluble, and binds tightly to serum albumin for transport to the liver.
Hepatic Conjugation: In hepatocytes, the enzyme uridine diphosphate glucuronosyltransferase (UGT1A1) catalyzes the conjugation of indirect bilirubin with glucuronic acid to form water-soluble conjugated (direct) bilirubin , which is excreted into bile and the intestine.
Enterohepatic Circulation: The neonatal intestine possesses low bacterial flora to convert bilirubin to stercobilin, but high concentrations of mucosal beta-glucuronidase . This enzyme deconjugates intestinal bilirubin back into unconjugated bilirubin, which is reabsorbed through the gut mucosa into the portal bloodstream.
Clinical Progression & Visual Assessment Pitfalls
Jaundice progresses in a cephalocaudal direction : appearing first on the face and sclera (~5 mg/dL), progressing to the chest and upper abdomen (~8 to 10 mg/dL), lower abdomen and thighs (~12 to 15 mg/dL), and finally the palms and soles (>15 to 20 mg/dL).
Visual estimation of bilirubin levels is notoriously subjective and unreliable, particularly in darkly pigmented infants.
Clinical Standard: Every jaundiced infant must be objectively evaluated using a transcutaneous bilirubinometer (TcB) or a venous total serum bilirubin (TSB) .
Physiologic vs. Pathologic Jaundice
Diagnostic Feature Physiologic Jaundice Pathologic Jaundice
Onset of Jaundice AFTER 24 to 36 hours of life (typically peaks at days 3 to 5) WITHIN THE FIRST 24 HOURS OF LIFE (Always pathologic!)
Rate of TSB Rise Slow, gradual: <5 mg/dL in 24 hours (<0.2 mg/dL/hour) Rapid: >5 mg/dL in 24 hours (>0.2 mg/dL/hour)
Peak TSB Concentrations Peak at 5 to 12 mg/dL on days 3 to 5 in term infants Exceeds the 95th percentile on the hour-specific Bhutani nomogram
Direct (Conjugated) Fraction Normal: Direct bilirubin <1.0 mg/dL Elevated: Direct bilirubin >1.0 mg/dL (or >20% of total TSB)
Duration Resolves by 1 to 2 weeks in term infants (by 3 weeks in preterm) Persists beyond 2 weeks of life in term infants
Primary Etiologies Combination of high RBC turnover, immature hepatic UGT1A1 enzyme activity, and elevated enterohepatic reabsorption Hemolytic Disease: ABO incompatibility (Maternal O, Infant A/B), Rh isoimmunization (positive Coombs/DAT), G6PD deficiency, hereditary spherocytosis.; Non-Hemolytic: Cephalohematoma, polycythemia, sepsis, biliary atresia, galactosemia.
Breastfeeding Jaundice vs. Breast Milk Jaundice
A frequent area of confusion on clinical exams is the differentiation between early intake-related jaundice and true breast milk jaundice: Jaundice in the Breastfed Infant
├── Breastfeeding Jaundice (Suboptimal Intake) ──> Days 2 to 5 ──> Dehydration, weight loss, delayed stooling ──> Optimize feeds
└── Breast Milk Jaundice (Late-Onset Benign) ──> Days 5 to 14 ──> Thriving infant, normal gain, lasts weeks ──> Continue nursing
Breastfeeding Jaundice (Suboptimal Intake Jaundice / Early-Onset):
Timing: Manifests in the first 2 to 5 days of life .
Pathophysiology: Inadequate caloric and fluid intake due to delayed lactogenesis, poor latch, or infrequent feedings leads to mild dehydration, delayed stooling, and slow meconium transit, which drastically increases the enterohepatic reabsorption of unconjugated bilirubin.
Clinical Signs: Weight loss >8% to 10% , decreased wet diapers (<3/day), delayed passage of meconium, lethargy, concentrated uric acid "brick dust" crystals in urine.
Midwifery Management: Optimize breastfeeding frequency ( 8 to 12 feedings per 24 hours ), evaluate latch and milk transfer with a lactation consultant, and supplement with expressed breast milk, donor milk, or formula if dehydration, excessive weight loss, or high bilirubin levels persist. Breastfeeding should NOT be discontinued.
Breast Milk Jaundice (Late-Onset):
Timing: Onset occurs in late week 1 ( days 5 to 7 ), peaks during weeks 2 to 3, and gradually resolves over 3 to 12 weeks .
Pathophysiology: Substances naturally present in mature maternal breast milk (e.g., beta-glucuronidase , non-esterified free fatty acids, and epidermal growth factor) inhibit hepatic UGT1A1 conjugation or enhance intestinal deconjugation.
Clinical Signs: The infant is completely healthy, alert, thriving, gaining weight vigorously , voiding normally, and passing soft yellow seedy stools.
Midwifery Management: Reassurance. Phototherapy is initiated only if TSB exceeds AAP risk thresholds. Breastfeeding should NOT be interrupted ; temporary cessation is unnecessary and disrupts the lactation relationship.
Phototherapy & Exchange Transfusion Guidelines
The AAP Hour-Specific Nomogram (Bhutani Nomogram): Guides clinical intervention by plotting total serum bilirubin against infant post-natal age in hours, stratified by gestational age (≥38 weeks vs. 35–37 weeks) and the presence of neurotoxicity risk factors (e.g., positive DAT/Coombs hemolysis, G6PD deficiency, sepsis, asphyxia, serum albumin <3.0 g/dL).
Mechanism of Phototherapy: Narrow-band blue-green light (wavelength 460 to 490 nm) penetrates superficial skin capillaries. Photons hit unconjugated bilirubin molecules, driving a structural photoisomerization reaction that converts toxic, lipid-soluble 4Z,15Z-bilirubin into lumirubin . Lumirubin is a stable, water-soluble structural isomer that does NOT require hepatic glucuronide conjugation and is excreted directly into bile and urine.
Midwifery Nursing Care During Phototherapy:
Maximize exposed skin surface area (infant wears only a small diaper).
Place opaque protective eye shields over the infant's eyes to prevent phototoxic retinal damage; remove shields during feedings to evaluate eyes and promote bonding.
Maintain infant thermal neutrality under lights; monitor temperature closely.
Ensure optimal enteral hydration to facilitate urinary and fecal lumirubin excretion.
Turn off phototherapy lights when drawing blood for bilirubin levels to avoid photodegradation in the specimen tube.
Bronze Baby Syndrome: An unusual, dark grayish-brown discoloration of the skin, serum, and urine occurring when phototherapy is inadvertently applied to infants with elevated direct (conjugated) hyperbilirubinemia (cholestatic jaundice), caused by photo-oxidation of retained copper porphyrins. Phototherapy is contraindicated in cholestasis.
Exchange Transfusion & Acute Bilirubin Encephalopathy (ABE):
Reserved for severe hyperbilirubinemia where TSB reaches or exceeds exchange transfusion thresholds, or when the infant exhibits intermediate-to-advanced signs of Acute Bilirubin Encephalopathy (ABE) :
Early Phase: Lethargy, poor feeding, mild hypotonia.
Intermediate Phase: Stupor, irritability, high-pitched shrill cry, hypertonia, retrocollis (neck arching backward) , and opisthotonos (severe trunk arching backward) .
Advanced Phase: Inconsolable crying, inability to feed, bicycling movements, apnea, intractable seizures, coma, and death.
Kernicterus (Chronic Bilirubin Encephalopathy): Permanent, irreversible neurodevelopmental damage caused by unconjugated bilirubin depositing in the basal ganglia (especially the globus pallidus) , subthalamic nuclei, and auditory brainstem pathways. The classic tetrad of kernicterus includes:
- Choreoathetoid cerebral palsy (involuntary, uncoordinated movements)
- Sensorineural hearing loss / auditory neuropathy
- Upward gaze palsy (paralysis of upward conjugate ocular movement)
Dental enamel dysplasia of primary deciduous teeth.